Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension.

Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr. Kariadi Central General Hospital

Semarang, Central of Java, Indonesia

Location status: Recruiting

Location contact

Leo Deddy Pradipta

CONTACT

[email protected]

+6281316499074

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Essential hypertension

Exclusion criteria

Secondary or resistant hypertension
LVEF<55%
Congenital heart disease
Infiltrative cardiomyopathy
Coronary artery disease
Chronic kidney disease
Valvular heart disease
Bundle branch block
Arrhythmia

Treatment and study plan

Echocardiohraphy

Diagnostic Test

Transthoracal echocardiography for diastolic function assessment

Primary outcomes

Diastolic Dysfunction

Time frame: Up to 1 weeks

Diastolic Dysfunction found in transthoracal echocardiography assessment

Study contacts

Contact information is provided by the study sponsor or research team.

Leo Deddy Pradipta

CONTACT

[email protected]

+6281316499074

Sponsors and collaborators

Lead sponsor

Universitas Diponegoro

Other

Registry information

Acronym: VANESSA

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Jan 16, 2025
Registry last updated: Jan 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting